By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Paolo Macchiarini affair: I reproduce the letter Patricia Murray, Raphael Levy, Peter Wilmshurst and myself published in The BMJ on 2 March 2022. I also publish Wilmshurst’s appeal to the UCL leadership.
In this 3rd instalment of her Celixir investigation, Patricia Murray learns whose side the British authority MHRA is on. Not the patients’, and certainly not on the side of facts.
Liverpool professor Patricia Murray continues investigating shady dealings of the regmed company Celixir, owned by struck-off dentist Ajan Reginald and Nobelist Sir Martin Evans
Patricia Murray uncovers the business secrets of the Nobelist Martin Evans and his partner Ajan Reginald. It seems the magic iMP cells used to treat patients in Greece were drawn from the blood of patients in Swansea, for the purpose of a secret PhD thesis. There is no serious science behind it, only serious investor money and a fraudulent patent.
The Science and Technology Committee of the British House of Commons is now dealing with the trachea transplants performed byContinue Reading
Here I republish the written evidence submitted to by two UK scientists to the Science and Technology Committee of the BritishContinue Reading
For Better Science